Clinical Trials
2 trialsNCT05104281 2023-03-29
Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer
Qingdao Central Hospital
Phase 3 Unknown
NCT02972333 2016-11-23
Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M
Shandong Cancer Hospital and Institute
Phase 3 Unknown